Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...
Le Lézard2 小时
Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides ...
Citius Oncology, Inc. ("Citius Oncology" or the "Company") , a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported ...